Fulgent Genetics Inc expected to post earnings of $2.76 a share - Earnings Preview

Fulgent Genetics

07/08/2021 24:15

* Fulgent Genetics Inc  FLGT.OQ   FLGT.O  is expected to show a
rise in quarterly revenue when it reports results on August 9. 
* The Temple City, California-based company is expected to
report   a 1,043.0% increase in revenue to $197.343 million from
$17.27 million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Fulgent Genetics Inc is
for earnings of $2.76 per share. For the same quarter last year,
the company reported earnings of 17 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Fulgent
Genetics Inc is $118​, about 10.4% above​ its last closing price
of $105.76. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  5.82        5.86       6.59      Beat    12.5
 Dec. 31 2020  4.30        4.05       6.20      Beat    52.9
 Sep. 30 2020  0.55        0.55       2.08      Beat    277.3​
 Jun. 30 2020  -0.01       -0.02      0.17      Beat    1,044.
                                                        4
 Mar.          0.02​       0.02       -0.03     Missed  -242.9
 31​ 2020​                                              ​
 Dec. 31 2019              0.04       0.04      Met     1.3​
 Sep. 30 2019  0.03        0.03       0.14      Beat    344.4
 Jun. 30 2019  0.00        0.00       0.06      Beat    4,100
 This summary was machine generated August 6 at 23:15 GMT.  All
figures in US dollars unless otherwise stated